FINWIRES · TerminalLIVE
FINWIRES

JD Health International's Profit Jumps 78% in Q1; Share Buyback Proposed

By

JD Health International (HKG:6618) recorded a 78% rise in attributable profit in the first quarter of 2026 to 1.66 billion yuan from 934.4 million yuan a year prior, according to a Tuesday Hong Kong bourse filing.

The online healthcare platform's revenue for the three months jumped 17% to 19.5 billion yuan from 16.6 billion yuan in the prior-year period.

The firm is also planning to buy back up to $1 billion of shares from the open market over 48 months, pending approval, according to a separate stock exchange filing.

Related Articles

Asia

Marksans Pharma Board to Consider Dividend for Fiscal 2026

Marksans Pharma (NSE:MARKSANS, BOM:524404) said its board of directors will meet on May 26 to consider the declaration of dividend for the financial year 2025-26, according to a filing with the Indian bourses on Tuesday.

$BOM:524404$NSE:MARKSANS
Asia

KNR Constructions Arm Signs Concession Agreement for Telangana Road Project in India

KNR Constructions (NSE:KNRCON, BOM:532942) subsidiary KNR Manyamkonda Infra signed a concession agreement with the National Highways Authority of India for a highway project in Telangana, India.The project involves four-laning of an 80.01-kilometer stretch of NH-167 from Gudebellur to Mahabubnagar under the hybrid annuity mode, the Tuesday filing said.The agreement was signed Monday.

$BOM:532942$NSE:KNRCON
Asia

Vishnu Chemicals Resumes Operations at Parwada Plant

Vishnu Chemicals (NSE:VISHNU, BOM:516072) resumed full operations at its Parwada plant in Visakhapatnam, Andhra Pradesh, according to a Tuesday filing.The plant was temporarily shut for maintenance activities, the filing said.

$BOM:516072$NSE:VISHNU